Literature DB >> 8390914

Heme-biosynthetic enzyme activities and porphyrin accumulation in normal liver and hepatoma cell lines of rat.

M Kondo1, N Hirota, T Takaoka, M Kajiwara.   

Abstract

The activities of four heme-biosynthetic enzymes, delta-aminolevulinic acid (ALA) synthase, ALA dehydratase, porphobilogen (PBG) deaminase, and ferrochelatase, were studied in five epithelial cell lines of normal rat liver origin (RL, RLC-10, RLC-24, M, Culb-TC) and five cell lines derived from Yoshida ascites hepatoma (JTC-1, JTC-2, JTC-15, JTC-16, JTC-24). The JTC series of hepatoma-derived cell lines exhibited decreased ALA synthase activity and increased ALA dehydratase activity, although the activities of all four enzymes and the Km values for their respective substrates varied widely from one cell line to another, a finding suggesting that specific regulatory mechanisms for porphyrin metabolism might operate in each cell type. M cells, which were transformed by 4-dimethylaminoazobenzene in vitro, gave the most abnormal Km values of heme-biosynthetic enzymes among all the cell lines studies, and were found to accumulate hematoporphyrin derivative (HpD).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390914     DOI: 10.1007/bf00755143

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  7 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Purification and properties of uroporphyrinogen I synthase from human erythrocytes. Identification of stable enzyme-substrate intermediates.

Authors:  P M Anderson; R J Desnick
Journal:  J Biol Chem       Date:  1980-03-10       Impact factor: 5.157

3.  Induction of delta-aminolevulinic acid synthase and delta-aminolevulinic acid dehydratase in normal human bone marrow cultures.

Authors:  S Shionoya; A Urabe; Y Hashimoto; M Kondo; G Urata
Journal:  Stem Cells       Date:  1982       Impact factor: 6.277

4.  Hepatocellular carcinoma in patients with acute intermittent porphyria.

Authors:  F Lithner; L Wetterberg
Journal:  Acta Med Scand       Date:  1984

5.  Aberrant porphyrin metabolism in hepatocellular carcinoma.

Authors:  M Udagawa; Y Horie; C Hirayama
Journal:  Biochem Med       Date:  1984-04

6.  Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer.

Authors:  Y Hayata; H Kato; C Konaka; R Amemiya; J Ono; I Ogawa; K Kinoshita; H Sakai; H Takahashi
Journal:  Chest       Date:  1984-08       Impact factor: 9.410

7.  Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts.

Authors:  H L Bonkowsky; J R Bloomer; P S Ebert; M J Mahoney
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

  7 in total
  12 in total

1.  Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.

Authors:  Maria Bernadete Riemma Pierre; Eduardo Ricci; Antonio Cláudio Tedesco; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

2.  Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells.

Authors:  Martin Hefti; Ina Albert; Vera Luginbuehl
Journal:  J Neurooncol       Date:  2012-04-15       Impact factor: 4.130

3.  Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.

Authors:  Sanjay Anand; Golara Honari; Tayyaba Hasan; Paul Elson; Edward V Maytin
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

Review 4.  Fluorescence-guided surgery for brain tumors.

Authors:  Martin Hefti
Journal:  CNS Oncol       Date:  2013-01

5.  Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.

Authors:  Renjith P Johnson; Chung-Wook Chung; Young-Il Jeong; Dae Hwan Kang; Hongsuk Suh; Il Kim
Journal:  Int J Nanomedicine       Date:  2012-05-17

6.  Nuclear distribution of porphobilinogen deaminase (PBGD) in glioma cells: a regulatory role in cancer transformation?

Authors:  L Greenbaum; Y Gozlan; D Schwartz; D J Katcoff; Z Malik
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

7.  The Role of 5-ALA in Low-Grade Gliomas and the Influence of Antiepileptic Drugs on Intraoperative Fluorescence.

Authors:  Sergey A Goryaynov; Georg Widhalm; Maria F Goldberg; Danil Chelushkin; Aldo Spallone; Kosta A Chernyshov; Marina Ryzhova; Galina Pavlova; Alexander Revischin; Ludmila Shishkina; Vadim Jukov; Tatyana Savelieva; Loschenov Victor; Alexander Potapov
Journal:  Front Oncol       Date:  2019-05-22       Impact factor: 6.244

8.  Review of photodynamic therapy in actinic keratosis and basal cell carcinoma.

Authors:  Marica B Ericson; Ann-Marie Wennberg; Olle Larkö
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

9.  Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma.

Authors:  M Otake; M Nishiwaki; Y Kobayashi; S Baba; E Kohno; T Kawasaki; Y Fujise; H Nakamura
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

10.  Implementation of a red blood cell-optical (RBO) channel for detection of latent iron deficiency anaemia by automated measurement of autofluorescence-emitting red blood cells.

Authors:  Takahiro Tougan; Sawako Itagaki; Yuji Toya; Kinya Uchihashi; Toshihiro Horii
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.